UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 39

Sortiert nach

A characterization of Gaucher iPS-derived astrocytes: Potential implications for Parkinson's disease

Neurobiology of disease, 2020-02, Vol.134, p.104647-104647, Article 104647

2020

Volltextzugriff (PDF)

Macrophage models of Gaucher disease for evaluating disease pathogenesis and candidate drugs

Science translational medicine, 2014-06, Vol.6 (240), p.240ra73

2014

Volltextzugriff (PDF)

Induced pluripotent stem cell model recapitulates pathologic hallmarks of Gaucher disease

Proceedings of the National Academy of Sciences - PNAS, 2012-10, Vol.109 (44), p.18054-18059

2012

Volltextzugriff (PDF)

A New Glucocerebrosidase Chaperone Reduces α-Synuclein and Glycolipid Levels in iPSC-Derived Dopaminergic Neurons from Patients with Gaucher Disease and Parkinsonism

The Journal of neuroscience, 2016-07, Vol.36 (28), p.7441-7452

2016

Volltextzugriff (PDF)

Glucocerebrosidase is present in α-synuclein inclusions in Lewy body disorders

Acta neuropathologica, 2010-11, Vol.120 (5), p.641-649

2010

Volltextzugriff (PDF)

EEG abnormalities in patients with chronic neuronopathic Gaucher disease: A retrospective review

Molecular genetics and metabolism, 2020-11, Vol.131 (3), p.358-363

2020

Volltextzugriff (PDF)

Reciprocal and Nonreciprocal Recombination at the Glucocerebrosidase Gene Region: Implications for Complexity in Gaucher Disease

American journal of human genetics, 2003-03, Vol.72 (3), p.519-534

2003

Volltextzugriff (PDF)

Alleles with more than one mutation can complicate genotype/phenotype studies in Mendelian disorders: Lessons from Gaucher disease

Molecular genetics and metabolism, 2018-09, Vol.125 (1-2), p.1-3

2018

Volltextzugriff (PDF)

DNA Targeting of Rhinal Cortex D2 Receptor Protein Reversibly Blocks Learning of Cues That Predict Reward

Proceedings of the National Academy of Sciences - PNAS, 2004-08, Vol.101 (33), p.12336-12341

2004

Volltextzugriff (PDF)

Myoclonic epilepsy in Gaucher disease: Genotype-phenotype insights from a rare patient subgroup

Pediatric research, 2003-03, Vol.53 (3), p.387-395

2003

Volltextzugriff (PDF)

A mutation in SCARB2 is a modifier in gaucher disease

Human mutation, 2011-11, Vol.32 (11), p.1232-1238

2011

Volltextzugriff (PDF)

Evaluation of Quinazoline Analogues as Glucocerebrosidase Inhibitors with Chaperone Activity

Journal of medicinal chemistry, 2011-02, Vol.54 (4), p.1033-1058

2011

Volltextzugriff (PDF)

Glucocerebrosidase mutations in Chinese subjects from Taiwan with sporadic Parkinson disease

Molecular genetics and metabolism, 2007-06, Vol.91 (2), p.195-200

2007

Volltextzugriff (PDF)

Phenotypic continuum in neuronopathic gaucher disease: an intermediate phenotype between type 2 and type 3

The Journal of pediatrics, 2003-08, Vol.143 (2), p.273-276

2003

Volltextzugriff (PDF)

A germline or de novo mutation in two families with Gaucher disease: implications for recessive disorders

European journal of human genetics : EJHG, 2013-01, Vol.21 (1), p.115-117

2013

Volltextzugriff (PDF)

Identification of recombinant alleles using quantitative real-time PCR implications for Gaucher disease

The Journal of molecular diagnostics : JMD, 2011-07, Vol.13 (4), p.401-405

2011

Volltextzugriff (PDF)

False-positive results using a Gaucher diagnostic kit – RecTL and N370S

Molecular genetics and metabolism, 2010-05, Vol.100 (1), p.100-102

2010

Volltextzugriff (PDF)

Identification of Recombinant Alleles Using Quantitative Real-Time PCR

The Journal of molecular diagnostics : JMD, 2011, Vol.13 (4), p.401-405

2011

Volltextzugriff (PDF)

A mutation in the human glucocerebrosidase gene in neuronopathic Gaucher's disease

The New England journal of medicine, 1987-03, Vol.316 (10), p.570

1987

Volltextzugriff (PDF)

In silico and functional studies of the regulation of the glucocerebrosidase gene

Molecular genetics and metabolism, 2010-03, Vol.99 (3), p.275-282

2010

Volltextzugriff (PDF)

A characterization of Gaucher iPS-derived astrocytes: Potential implications for Parkinson disease

Neurobiology of disease, 2019-11, Vol.134, p.104647-104647

2019

Volltextzugriff (PDF)

108 Mutant glucocerebrosidase and the synucleinopathies

Molecular genetics and metabolism, 2007-12, Vol.92 (4), p.33-33

2007

Volltextzugriff (PDF)

Genotypic heterogeneity and phenotypic variation among patients with type 2 Gaucher's disease

Pediatric research, 1998-05, Vol.43 (5), p.571-578

1998

Volltextzugriff (PDF)

Patient-derived Gaucher induced pluripotent stem cells as a tool to understand common complex disorders

Molecular genetics and metabolism, 2018-02, Vol.123 (2), p.S128-S128

2018

Volltextzugriff (PDF)

A New Glucocerebrosidase Chaperone Reduces -Synuclein and Glycolipid Levels in iPSC-Derived Dopaminergic Neurons from Patients with Gaucher Disease and Parkinsonism

The Journal of neuroscience, 2016-07, Vol.36 (28), p.7441-7452

2016

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Aktive Filter

KollektionEZB Free E-Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(39)

Sprache

Englisch
(39)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A characterization of Gaucher iPS-derived astrocytes: Potential implications for Parkinson's disease

Macrophage models of Gaucher disease for evaluating disease pathogenesis and candidate drugs

Induced pluripotent stem cell model recapitulates pathologic hallmarks of Gaucher disease

A New Glucocerebrosidase Chaperone Reduces α-Synuclein and Glycolipid Levels in iPSC-Derived Dopaminergic Neurons from Patients with Gaucher Disease and Parkinsonism

Glucocerebrosidase is present in α-synuclein inclusions in Lewy body disorders

EEG abnormalities in patients with chronic neuronopathic Gaucher disease: A retrospective review

Reciprocal and Nonreciprocal Recombination at the Glucocerebrosidase Gene Region: Implications for Complexity in Gaucher Disease

Alleles with more than one mutation can complicate genotype/phenotype studies in Mendelian disorders: Lessons from Gaucher disease

DNA Targeting of Rhinal Cortex D2 Receptor Protein Reversibly Blocks Learning of Cues That Predict Reward

Myoclonic epilepsy in Gaucher disease: Genotype-phenotype insights from a rare patient subgroup

A mutation in SCARB2 is a modifier in gaucher disease

Evaluation of Quinazoline Analogues as Glucocerebrosidase Inhibitors with Chaperone Activity

Glucocerebrosidase mutations in Chinese subjects from Taiwan with sporadic Parkinson disease

Phenotypic continuum in neuronopathic gaucher disease: an intermediate phenotype between type 2 and type 3

A germline or de novo mutation in two families with Gaucher disease: implications for recessive disorders

Identification of recombinant alleles using quantitative real-time PCR implications for Gaucher disease

False-positive results using a Gaucher diagnostic kit – RecTL and N370S

Identification of Recombinant Alleles Using Quantitative Real-Time PCR

A mutation in the human glucocerebrosidase gene in neuronopathic Gaucher's disease

In silico and functional studies of the regulation of the glucocerebrosidase gene

A characterization of Gaucher iPS-derived astrocytes: Potential implications for Parkinson disease

108 Mutant glucocerebrosidase and the synucleinopathies

Genotypic heterogeneity and phenotypic variation among patients with type 2 Gaucher's disease

Patient-derived Gaucher induced pluripotent stem cells as a tool to understand common complex disorders

A New Glucocerebrosidase Chaperone Reduces -Synuclein and Glycolipid Levels in iPSC-Derived Dopaminergic Neurons from Patients with Gaucher Disease and Parkinsonism

Aktive Filter

Suchergebnisse filtern